0.83 USD
↘ 0.03 (3.09%)AT CLOSE (03:59 PM EST)
BioNexus Gene Lab Corp Common stock (BGLC) is currently trading at $0.83. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BGLC is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 6, 2026.